Monjuvi: how long were the pivotal tox studies?

“The safety of tafasitamab was evaluated in GLP-compliant 8- and 13-week general toxicology studies in cynomolgus monkeys.”

“once every two weeks at 2, 10 or 50 mg/kg in the 8-week study, or once every week at 0, 10, 30 or 100 mg/kg in the 13-week study.”

“All general toxicology studies performed used the intended route for human use (i.e., intravenous administration via infusion) and included concomitant toxicokinetics”